It appears that DPP4 plays a small but noticeable role in BBB infection (and only in the absence of ACE2) since gliptin drugs have been demonstrated to directly interfere with the binding site exploited by the SARS-CoV-2 spike [67]. The gene discussed is DPP4; the disease is infection.